Publicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (15)

2024

  1. Recurrent alcohol-associated hepatitis is common and is associated with increased mortality

    Hepatology, Vol. 80, Núm. 3, pp. 621-632

2023

  1. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

    Research and Practice in Thrombosis and Haemostasis, Vol. 7, Núm. 7

2022

  1. Author Correction: Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension (Scientific Reports, (2022), 12, 1, (5289), 10.1038/s41598-022-09353-z)

    Scientific Reports

  2. Efficacy and Safety of Tinzaparin in Prophylactic, Intermediate and Therapeutic Doses in Non-Critically Ill Patients Hospitalized with COVID-19: The PROTHROMCOVID Randomized Controlled Trial

    Journal of Clinical Medicine, Vol. 11, Núm. 19

2021

  1. Clinical characterization and outcomes of 85 patients with neurosarcoidosis

    Scientific Reports, Vol. 11, Núm. 1

  2. Coexistence of immune-mediated diseases in sarcoidosis. Frequency and clinical significance in 1737 patients

    Joint Bone Spine, Vol. 88, Núm. 6

  3. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  4. Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs

    Thrombosis and Haemostasis, Vol. 121, Núm. 12, pp. 1650-1659

2020

  1. Deep-sequencing reveals broad subtype-specific HCV resistance mutations associated with treatment failure

    Antiviral Research, Vol. 174

  2. Virological outcome among HIV infected patients transferred from pediatric care to adult units in Madrid, Spain (1997–2017)

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Systemic phenotype of sarcoidosis associated with radiological stages. Analysis of 1230 patients

    European Journal of Internal Medicine, Vol. 69, pp. 77-85

2017

  1. High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4

    Liver International, Vol. 37, Núm. 12, pp. 1823-1832

  2. Predictors of active cancer thromboembolic outcomes: RIETE experience of the Khorana score in cancer-associated thrombosis

    Thrombosis and Haemostasis, Vol. 117, Núm. 6, pp. 1192-1198

2016

  1. Sarcoidosis: an update on current pharmacotherapy options and future directions

    Expert Opinion on Pharmacotherapy, Vol. 17, Núm. 18, pp. 2431-2448

2007

  1. Factores predictivos del riesgo de enfermedad cardiovascular en los pacientes con diabetes tipo 2 e hipercolesterolemia. Estudio ESODIAH

    Revista Espanola de Cardiologia, Vol. 60, Núm. 3, pp. 251-258